Similar Articles
1801 Post-radiation survival time in hepatocellular carcinoma based on predictors for CT-determined, transarterial embolization and various other parameters
1802 Expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival
1803 Impact of pre-operative transarterial embolization on the treatment of hepatocellular carcinoma with liver transplantation
1804 Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy
1805 Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma
1806 Impact of prolonged fraction dose-delivery time modeling intensity-modulated radiation therapy on hepatocellular carcinoma cell killing
1807 Tissue microarray for high-throughput analysis of gene expression profiles in hepatocellular carcinoma
1808 Expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma
1809 Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis
1810 Expression of p57kip2 and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA